Robert W. Baird Increases Owens & Minor (NYSE:OMI) Price Target to $28.00

Owens & Minor (NYSE:OMI) had its price objective hoisted by Robert W. Baird from $24.00 to $28.00 in a research note published on Wednesday, Benzinga reports. The firm currently has a neutral rating on the stock.

A number of other analysts have also recently commented on OMI. TheStreet raised Owens & Minor from a d+ rating to a c- rating in a research note on Monday, March 4th. StockNews.com raised Owens & Minor from a hold rating to a buy rating in a research note on Wednesday, February 21st. Leerink Partnrs reissued a market perform rating on shares of Owens & Minor in a research note on Monday, February 26th. Barclays increased their target price on Owens & Minor from $21.00 to $23.00 and gave the stock an equal weight rating in a research note on Wednesday, February 21st. Finally, UBS Group lowered their target price on Owens & Minor from $28.00 to $26.00 and set a buy rating for the company in a research note on Monday, January 29th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of Hold and an average price target of $23.29.

Owens & Minor Price Performance

Shares of OMI opened at $25.58 on Wednesday. The stock has a market cap of $1.96 billion, a P/E ratio of -47.37, a price-to-earnings-growth ratio of 0.82 and a beta of 0.43. Owens & Minor has a 1 year low of $13.34 and a 1 year high of $28.35. The stock’s 50-day moving average price is $24.46 and its two-hundred day moving average price is $20.54. The company has a current ratio of 1.11, a quick ratio of 0.52 and a debt-to-equity ratio of 2.05.

Owens & Minor (NYSE:OMI) last announced its quarterly earnings results on Tuesday, February 20th. The company reported $0.69 EPS for the quarter, beating analysts’ consensus estimates of $0.66 by $0.03. The company had revenue of $2.66 billion during the quarter, compared to analysts’ expectations of $2.67 billion. Owens & Minor had a positive return on equity of 11.62% and a negative net margin of 0.40%. Owens & Minor’s revenue was up 4.1% on a year-over-year basis. During the same period in the prior year, the business posted $0.28 EPS. On average, equities analysts predict that Owens & Minor will post 1.54 earnings per share for the current year.

Insiders Place Their Bets

In other Owens & Minor news, SVP Michael Wayne Lowry sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 27th. The stock was sold at an average price of $25.00, for a total transaction of $250,000.00. Following the completion of the transaction, the senior vice president now owns 71,654 shares of the company’s stock, valued at approximately $1,791,350. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Owens & Minor news, SVP Jonathan A. Leon sold 7,500 shares of the company’s stock in a transaction that occurred on Wednesday, January 17th. The stock was sold at an average price of $18.08, for a total transaction of $135,600.00. Following the completion of the transaction, the senior vice president now owns 83,213 shares of the company’s stock, valued at approximately $1,504,491.04. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP Michael Wayne Lowry sold 10,000 shares of the stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $25.00, for a total value of $250,000.00. Following the completion of the sale, the senior vice president now directly owns 71,654 shares of the company’s stock, valued at approximately $1,791,350. The disclosure for this sale can be found here. Insiders own 3.59% of the company’s stock.

Institutional Investors Weigh In On Owens & Minor

Several large investors have recently made changes to their positions in the stock. Advisor Group Holdings Inc. boosted its holdings in shares of Owens & Minor by 10.1% in the 1st quarter. Advisor Group Holdings Inc. now owns 4,858 shares of the company’s stock valued at $214,000 after buying an additional 444 shares during the last quarter. US Bancorp DE boosted its holdings in shares of Owens & Minor by 67.4% in the 1st quarter. US Bancorp DE now owns 1,145 shares of the company’s stock valued at $51,000 after buying an additional 461 shares during the last quarter. Delphia USA Inc. boosted its holdings in shares of Owens & Minor by 8.2% in the 1st quarter. Delphia USA Inc. now owns 6,163 shares of the company’s stock valued at $271,000 after buying an additional 469 shares during the last quarter. Baird Financial Group Inc. boosted its holdings in shares of Owens & Minor by 3.5% in the 1st quarter. Baird Financial Group Inc. now owns 14,784 shares of the company’s stock valued at $650,000 after buying an additional 503 shares during the last quarter. Finally, GAMMA Investing LLC boosted its holdings in shares of Owens & Minor by 52.1% in the 1st quarter. GAMMA Investing LLC now owns 1,644 shares of the company’s stock valued at $46,000 after buying an additional 563 shares during the last quarter. Institutional investors and hedge funds own 98.04% of the company’s stock.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.